Published in Infect Immun on June 01, 2002
GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T, B, and dendritic cell maturation. J Immunol (2012) 1.11
Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations. Immunology (2003) 0.94
Topical vaccination: the skin as a unique portal to adaptive immune responses. Semin Immunopathol (2007) 0.86
Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice. J Immunother (2005) 0.86
Transcutaneous immunization with cross-reacting material CRM(197) of diphtheria toxin boosts functional antibody levels in mice primed parenterally with adsorbed diphtheria toxoid vaccine. Infect Immun (2008) 0.82
Immunological activation following transcutaneous delivery of HR-gp100 protein. Vaccine (2007) 0.80
Hib Vaccines: Past, Present, and Future Perspectives. J Immunol Res (2016) 0.75
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol (1989) 31.72
T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol (1978) 28.92
Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev (1992) 5.15
On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J Immunol (1991) 2.49
Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat Med (2000) 1.98
Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity. J Exp Med (1998) 1.98
The skin immune system: progress in cutaneous biology. Immunol Today (1993) 1.76
Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol Today (1999) 1.74
Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc Natl Acad Sci U S A (1996) 1.73
Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J Exp Med (1997) 1.61
Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur J Immunol (1997) 1.56
Skin immunization made possible by cholera toxin. Nature (1998) 1.55
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine (2001) 1.49
Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants. Infect Immun (2000) 1.48
Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. J Immunol (1998) 1.41
Delineation of several DR-restricted tetanus toxin T cell epitopes. J Immunol (1989) 1.41
Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants. Infect Immun (1999) 1.32
CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G). J Virol (2002) 1.32
The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT). Vaccine (1999) 1.28
Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci (1996) 1.18
Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity. J Immunol (2000) 1.16
Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin. Infect Immun (1997) 1.13
Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge. Immunology (2001) 1.00
Mechanisms of resistance to S. mansoni infection: the rat model. Parasitol Int (2000) 0.99
Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells. Infect Immun (1999) 0.99
Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy. Crit Rev Ther Drug Carrier Syst (2001) 0.98
Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells. Immunology (2002) 0.97
Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii. Infect Immun (2001) 0.96
Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines. Vaccine (1995) 0.95
Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant. J Immunol (1999) 0.91
Intranasal vaccines: forthcoming challenges. Pharm Sci Technolo Today (2000) 0.90
Genetically derived toxoids for use as vaccines and adjuvants. Vaccine (1999) 0.88
Antipeptide antibody responses following intranasal immunization: effectiveness of mucosal adjuvants. Infect Immun (2000) 0.87
LTK63 and LTR72, two mucosal adjuvants ready for clinical trials. Int J Med Microbiol (2000) 0.86
The bare skin and the nose as non-invasive routes for administering peptide vaccines. Vaccine (2001) 0.81
Laboratory protocols for the identification of Th cell epitopes on self-antigens in mice with systemic autoimmune diseases. J Immunol Methods (2000) 0.81
IgE sensitization to gelatin: the probable role of gelatin-containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines. Vaccine (2000) 0.77
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A (1996) 16.69
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science (2000) 16.04
Helicobacter pylori virulence and genetic geography. Science (1999) 7.64
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science (2000) 7.41
Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science (1995) 5.73
Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc Natl Acad Sci U S A (1986) 5.59
Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci U S A (2000) 5.07
Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc Natl Acad Sci U S A (1989) 4.87
Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc Natl Acad Sci U S A (1989) 4.78
XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol (1998) 4.51
A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci U S A (2006) 4.40
Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol (1995) 3.86
Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol (1987) 3.44
DNA element of Corynebacterium diphtheriae with properties of an insertion sequence and usefulness for epidemiological studies. J Bacteriol (1987) 3.26
Living dangerously: how Helicobacter pylori survives in the human stomach. Nat Rev Mol Cell Biol (2001) 2.99
PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J Biol Chem (1999) 2.92
Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J (1999) 2.75
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci U S A (1995) 2.63
High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol (1997) 2.59
Families of bacterial signal-transducing proteins. Mol Microbiol (1989) 2.59
Expression and immunological properties of the five subunits of pertussis toxin. Infect Immun (1987) 2.59
Counterselectable markers: untapped tools for bacterial genetics and pathogenesis. Infect Immun (1998) 2.54
The complete nucleotide sequence of the gene coding for diphtheria toxin in the corynephage omega (tox+) genome. Nucleic Acids Res (1983) 2.51
Repeat-associated phase variable genes in the complete genome sequence of Neisseria meningitidis strain MC58. Mol Microbiol (2000) 2.44
The cytopathic effect of HIV is associated with apoptosis. Virology (1991) 2.43
Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol (1995) 2.37
Did the inheritance of a pathogenicity island modify the virulence of Helicobacter pylori? Trends Microbiol (1997) 2.33
Positive transcriptional feedback at the bvg locus controls expression of virulence factors in Bordetella pertussis. Proc Natl Acad Sci U S A (1990) 2.27
Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells. Mol Microbiol (1993) 2.24
Why peptides? Their possible role in the evolution of MHC-restricted T-cell recognition. Immunol Today (1989) 2.23
Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc Natl Acad Sci U S A (1994) 2.19
Growth of Helicobacter pylori in media containing cyclodextrins. J Clin Microbiol (1993) 2.17
Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J Biol Chem (1995) 2.17
Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect Immun (1996) 2.14
Positive regulation of pertussis toxin expression. Proc Natl Acad Sci U S A (1988) 2.13
The small GTP binding protein rab7 is essential for cellular vacuolation induced by Helicobacter pylori cytotoxin. EMBO J (1997) 2.11
Structural and genetic analysis of the bvg locus in Bordetella species. Mol Microbiol (1991) 2.09
Dissecting human T cell responses against Bordetella species. J Exp Med (1988) 2.07
Molecular and cellular signatures of human vaccine adjuvants. Proc Natl Acad Sci U S A (2008) 2.02
The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med (2000) 2.02
RrgA is a pilus-associated adhesin in Streptococcus pneumoniae. Mol Microbiol (2007) 2.01
Evolutionary relationships in the genus Bordetella. Mol Microbiol (1987) 2.00
Promoter of the pertussis toxin operon and production of pertussis toxin. J Bacteriol (1987) 1.98
Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity. J Exp Med (1998) 1.98
The Fur repressor controls transcription of iron-activated and -repressed genes in Helicobacter pylori. Mol Microbiol (2001) 1.96
The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc Natl Acad Sci U S A (1998) 1.95
Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun (1995) 1.93
Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J Clin Invest (1998) 1.89
Pertussis toxin export requires accessory genes located downstream from the pertussis toxin operon. Mol Microbiol (1993) 1.89
Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J (1999) 1.88
Genetic characterization of Bordetella pertussis filamentous haemagglutinin: a protein processed from an unusually large precursor. Mol Microbiol (1990) 1.88
Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J Cell Biol (1996) 1.82
Evaluation of surgical gamma probes for radioguided sentinel node localisation. Eur J Nucl Med (1998) 1.82
Introduction of unmarked mutations in the Helicobacter pylori vacA gene with a sucrose sensitivity marker. Infect Immun (1997) 1.82
Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodies. Infect Immun (1995) 1.79
Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C. Vaccine (1992) 1.78
Synthetic peptides as antigens: pitfalls of conjugation methods. J Immunol Methods (1985) 1.76
Congenital anomalies and anthropometry of 42 individuals with deletions of chromosome 18q. Am J Med Genet (1999) 1.76
Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis. Mol Microbiol (1994) 1.75
Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer: potential new therapies and vaccines. Trends Biotechnol (1994) 1.74
Sequential activation and environmental regulation of virulence genes in Bordetella pertussis. EMBO J (1991) 1.73
Helicobacter pylori: host responses in peptic ulceration. Lancet (1993) 1.73
Identification and characterization of an operon of Helicobacter pylori that is involved in motility and stress adaptation. J Bacteriol (1997) 1.70
Phase variants of Bordetella bronchiseptica arise by spontaneous deletions in the vir locus. Mol Microbiol (1989) 1.70
Identification by immunoprecipitation of cauliflower mosaic virus in vitro major translation product with a specific serum against viroplasm protein. EMBO J (1982) 1.69
Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol (1997) 1.69
A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit. J Exp Med (1994) 1.68
Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Hum Retroviruses (1993) 1.67
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
Restriction map of corynebacteriophages beta c and beta vir and physical localization of the diphtheria tox operon. J Bacteriol (1981) 1.67
In vivo competition between self peptides and foreign antigens in T-cell activation. Nature (1988) 1.66
Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J Exp Med (1998) 1.65
Sequence requirements for plasmid nuclear import. Exp Cell Res (1999) 1.63
The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol (2001) 1.61
Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity. Proc Natl Acad Sci U S A (1988) 1.61
The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197. Nucleic Acids Res (1984) 1.60
Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosol. Mol Microbiol (1997) 1.60
Detection of papillomavirus DNA in human semen. Science (1986) 1.59
Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect Immun (1997) 1.57
Cellular microbiology emerging. Science (1996) 1.56
Integration of corynebacteriophages beta tox+, omega tox+, and gamma tox- into two attachment sites on the Corynebacterium diphtheriae chromosome. J Bacteriol (1983) 1.56
Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine (2013) 1.56
Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell. J Exp Med (2000) 1.55
Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin. Infect Immun (1997) 1.54
The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure. Mol Microbiol (1999) 1.53
Restriction endonuclease map of corynebacteriophage omega ctox+ isolated from the Park-Williams no. 8 strain of Corynebacterium diphtheriae. J Virol (1983) 1.52
Structure and binding properties of monoclonal antibodies to core histones from autoimmune mice. Mol Immunol (1993) 1.51
A rapid screening procedure to identify mini-Tn10 insertion mutants of Escherichia coli K-12 with altered adhesion properties. FEMS Microbiol Lett (1996) 1.49
Pertussis toxin promoter sequences involved in modulation. J Bacteriol (1989) 1.49
Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map. J Exp Med (1989) 1.49
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine (2001) 1.49
Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol. Infect Immun (1998) 1.48
Three conserved consensus sequences identify the NAD-binding site of ADP-ribosylating enzymes, expressed by eukaryotes, bacteria and T-even bacteriophages. Mol Microbiol (1996) 1.47
Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis (1996) 1.46
The effect of poly(ADP-ribosyl)ation on native and H1-depleted chromatin. A role of poly(ADP-ribosyl)ation on core nucleosome structure. J Biol Chem (1989) 1.46
Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. Eur J Cardiothorac Surg (2001) 1.45
Restriction endonuclease map of the nontoxigenic corynephage gamma c and its relationship to the toxigenic corynephage beta c. J Virol (1982) 1.44
Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. Int Immunol (1998) 1.44